Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Environment may play significant role in multiple sclerosis.
[Association between depression and cognitive decline in sclerosis multiplex patients].
What do people with MS want from a web-based resource to encourage increased physical activity behaviour?
Multiple sclerosis: Phases of disease improvement unrelated to relapses.
XIMINO (minocycline hydrochloride) capsule, extended release [Ranbaxy Laboratories Inc.]
Postpartum complicated by transverse myelitis.
Natalizumab Therapy for Highly Active Pediatric Multiple Sclerosis.
Differences In Multiple Sclerosis Relapse Rates Based On Patient Adherence, Average Daily Dose, And Persistence With Disease-Modifying Therapy: Observations Based on Real-World Data.
Review series on immune responses in neurodegenerative diseases: Oligodendrocyte-microglia cross-talk in the CNS.
Melanoma complicating treatment with natalizumab for multiple sclerosis.
Fingolimod treatment in multiple sclerosis leads to increased macular volume.
Contribution of cortical lesion subtypes at 7T MRI to physical and cognitive performance in MS.
The effect of an AFO-shaped elastic band on drop-foot gait in patients with central neurological lesions.
MRI measures should be a primary outcome endpoint in phase III randomised controlled trials in multiple sclerosis: Commentary.
Epidemiology of amyotrophic lateral sclerosis in Isfahan, Iran.
The Communicative Participation Item Bank (CPIB): Item bank calibration and development of a disorder-generic short form.
Elevated concentration of C-reactive protein is associated with pregnancy-related co-morbidities but not with relapse activity in multiple sclerosis.
Mouse hepatitis virus infection upregulates genes involved in innate immune responses.
Neuron-oligodendrocyte myelination co-culture derived from embryonic rat spinal cord and cerebral cortex.
[A Patient with Acute Limbic Encephalitis Associated with Anti-Glutamate Receptor Antibodies and Subsequent Optic Neuritis].
Network meta-analysis models to account for variability in treatment definitions: application to dose effects.
Baseline brain activity changes in patients with clinically isolated syndrome revealed by resting-state functional MRI.
The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide.
Neutralizing Nanobodies targeting diverse chemokines effectively inhibit chemokine function.
Labour-associated increase in C-reactive protein concentration is not predictive of postpartum relapse activity among mothers with multiple sclerosis.
Pages
« first
‹ previous
…
197
198
199
200
201
202
203
204
205
…
next ›
last »